Literature DB >> 30263278

Safety of using Escherichia coli bacteriophages as a sanitizing agent based on inflammatory responses in rats.

Ji-Yeon Hwang1, Jung-Eun Kim2, Yoon-Jae Song2, Jong-Hyun Park1.   

Abstract

Use of bacteriophages as sanitizing agents has received much attention. However, safety in humans is debatable. To determine inflammatory immune responses against bacteriophages, rats were treated with a 8 log plaque-forming cocktail of 5 bacteriophages for pathogenic Escherichia coli per day for 4 weeks. Food consumption, feeding efficiency, and body weight of rats treated with the cocktail were not different from controls. Phages were not detected in the sera of phage-fed rats with no changes in organ weights. Notable changes were not observed upon histopathological examination of the liver, kidney, and spleen. Pro-inflammatory cytokine mRNA expression, except COX-2 (2.4x increase), remained unaffected after treatment with the phage cocktail. No remarkable changes were observed for levels of 12 pro-inflammatory cytokines in sera. Inflammatory responses in rats orally treated with a phage cocktail were not observed. Bacteriophages for E. coli are indicated as immunologically safe in rats.

Entities:  

Keywords:  E. coli bacteriophage; phage-fed rat; pro-inflammatory cytokine

Year:  2016        PMID: 30263278      PMCID: PMC6049376          DOI: 10.1007/s10068-016-0050-6

Source DB:  PubMed          Journal:  Food Sci Biotechnol        ISSN: 1226-7708            Impact factor:   2.391


  28 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Old dogma, new tricks--21st Century phage therapy.

Authors:  Karl Thiel
Journal:  Nat Biotechnol       Date:  2004-01       Impact factor: 54.908

3.  Phage classification and characterization.

Authors:  Hans-W Ackermann
Journal:  Methods Mol Biol       Date:  2009

4.  Visualizing a complete Siphoviridae member by single-particle electron microscopy: the structure of lactococcal phage TP901-1.

Authors:  Cecilia Bebeacua; Livia Lai; Christina Skovgaard Vegge; Lone Brøndsted; Marin van Heel; David Veesler; Christian Cambillau
Journal:  J Virol       Date:  2012-11-07       Impact factor: 5.103

Review 5.  The next generation of bacteriophage therapy.

Authors:  Timothy K Lu; Michael S Koeris
Journal:  Curr Opin Microbiol       Date:  2011-08-23       Impact factor: 7.934

Review 6.  Reactive oxygen species in cell signaling.

Authors:  V J Thannickal; B L Fanburg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-12       Impact factor: 5.464

7.  In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli.

Authors:  Marietta Weiss; Emmanuel Denou; Anne Bruttin; Ruth Serra-Moreno; Marie-Lise Dillmann; Harald Brüssow
Journal:  Virology       Date:  2009-08-21       Impact factor: 3.616

8.  Inhibition of IL-6, TNF-alpha, and cyclooxygenase-2 protein expression by prostaglandin E2-induced IL-10 in bone marrow-derived dendritic cells.

Authors:  Hedi Harizi; Gualde Norbert; Harizi Hedi
Journal:  Cell Immunol       Date:  2004-04       Impact factor: 4.868

9.  T4 phages against Escherichia coli diarrhea: potential and problems.

Authors:  Emmanuel Denou; Anne Bruttin; Caroline Barretto; Catherine Ngom-Bru; Harald Brüssow; Sophie Zuber
Journal:  Virology       Date:  2009-04-01       Impact factor: 3.616

10.  T4 phage and its head surface proteins do not stimulate inflammatory mediator production.

Authors:  Paulina Miernikiewicz; Krystyna Dąbrowska; Agnieszka Piotrowicz; Barbara Owczarek; Justyna Wojas-Turek; Jagoda Kicielińska; Joanna Rossowska; Elżbieta Pajtasz-Piasecka; Katarzyna Hodyra; Katarzyna Macegoniuk; Kamila Rzewucka; Agnieszka Kopciuch; Tomasz Majka; Andrey Letarov; Eugene Kulikov; Henryk Maciejewski; Andrzej Górski
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.